THE RELATIONSHIP BETWEEN OBSTRUCTIVE SLEEP APNEA SYNDROME AND METABOLIC SYNDROME AT VINMEC TIMES CITY INTERNATIONAL HOSPITAL

Văn Đĩnh Nguyễn1,2,3,, Thị Hằng Cấn2,4, Duy Bộ Nguyễn5
1 Vinmec times city hospital
2 VinUniversity
3 Penn State University
4 Vinmec times City hospital
5 Pen State University

Main Article Content

Abstract

Objective: Describe the clinical and subclinical characteristics of patients with obstructive sleep apnea syndrome and the relationship between the severity of obstructive sleep apnea (OSA) and metabolic syndrome at Vinmec Times City hospital. Method: This descriptive - retrospective study was conducted on 97 patients who were underwent polysomnography with completed medical records with satisfy inclusion criteria, from January 2020 to December 2021 at Vinmec Times City hospital. Results: 82/97 (84.5%) patients had apnea- hyponea index (AHI) more than 5. The mean age of patients with obstructive sleep apnea was 45.1 ± 12.1. Male and female ratio was 4.46. Age, HbA1c, and BMI were positively correlated with AHI. Comparing 2 groups with or without metabolic syndrome: BMI, waist circumference, HbA1c, AHI were statistically significantly higher in OSA patients with metabolic syndrome. The lowest Sp02 was lower and the T90% was longer statistically significant in OSA patients with metabolic syndrome. Conclusion: There is a correlation between metabolic syndrome and OSA, and they share similarities in various factors. Metabolic syndrome has the potential to worsen sleep apnea, and conversely, sleep apnea may contribute to the development or progression of metabolic syndrome

Article Details

References

1. Lee W., Nagubadi S., Kryger M.H., et al. (2008). Epidemiology of obstructive sleep apnea: a population-based perspective. Expert Review of Respiratory Medicine, 2(3), 349–364.
2. Redline S. (2017). Obstructive sleep apnea: Phenotypes and genetics. Principles and Practice of Sleep Medicine. Elsevier, 1102-1109. e5.
3. Senaratna C.V., Perret J.L., Lodge C.J., et al. (2017). Prevalence of obstructive sleep apnea in the general population: A systematic review. Sleep Med Rev, 34, 70–81.
4. Charles W Atwood J. (2008). Obstructive Sleep Apnea: Pathophysiology, Comorbidities, and Consequences. Respiratory Care, 53(3), 380.
5. Margaret Gleeson and Walter T. McNicholas (2022). Bidirectional relationships of comorbidity with obstructive sleep apnoea. EUROPEAN RESPIRATORY REVIEW, 31(164), 210256.
6. Peppard P.E., Young T., Palta M., et al. (2000). Longitudinal Study of Moderate Weight Change and Sleep-Disordered Breathing. JAMA, 284(23), 3015–3021.
7. Jehan S., Zizi F., Pandi-Perumal S.R., et al. (2017). Obstructive sleep apnea and obesity: implications for public health. Sleep medicine and disorders: international journal, 1(4).
8. Tietjens J.R., Claman D., Kezirian E.J., et al. (2019). Obstructive Sleep Apnea in Cardiovascular Disease: A Review of the Literature and Proposed Multidisciplinary Clinical Management Strategy. Journal of the American Heart Association, 8(1), e010440.
9. Lin Q.-C., Zhang X.-B., Chen G.-P., et al. (2012). Obstructive sleep apnea syndrome is associated with some components of metabolic syndrome in nonobese adults. Sleep Breath, 16(2), 571–578.
10. Landry S.A. and Joosten S.A. (2018). Obstructive sleep apnoea and cholesterol: Independence in context. Respirology, 23(12), 1092–1093.